{"entity":{"type":"insider","cik":"0001422772","url":"/insider/0001422772","json_url":"/insider/0001422772.json","name":"Kim Helen Susan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":58,"n_filings":15,"first":"2008-03-17","last":"2026-01-12","span_basis":"filed_date"},"name_variants":[{"name":"Kim Helen Susan","source":"filing","n_filings":15,"first_seen":"2008-03-17","last_seen":"2026-01-12"}],"transactions":[{"id":6194265,"accession":"0001193125-26-010566","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-010566","line_url":"/filing/0001193125-26-010566","is_derivative":false,"issuer_cik":"0001422772","issuer_name":"Aktis Oncology, Inc.","issuer_ticker":"AKTS","issuer_name_source":null,"issuer_url":"/issuer/0001422772","owner_cik":"0001422772","owner_name":"Kim Helen Susan","owner_display_name":"Kim Helen Susan","owner_url":"/insider/0001422772","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":835000.0,"shares_display":"835,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":15030000.0,"total_display":"15,030,000.00","total_whole":"15,030,000","shares_owned_after":5671825.0,"shares_owned_after_display":"5,671,825","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-12","scope":"insider","n_lines":2},{"id":5164299,"accession":"0001209191-21-053763","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-053763","line_url":"/filing/0001209191-21-053763","is_derivative":false,"issuer_cik":"0001422772","issuer_name":"Applied Molecular Transport Inc.","issuer_ticker":"AMTI","issuer_name_source":null,"issuer_url":"/issuer/0001422772","owner_cik":"0001422772","owner_name":"Kim Helen Susan","owner_display_name":"Kim Helen Susan","owner_url":"/insider/0001422772","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":951.0,"shares_display":"951","price_per_share":30.940980336487907,"price_display":"30.94","price_state":"stated","total_value":29424.8723,"total_display":"29,424.87","total_whole":"29,425","shares_owned_after":575250.0,"shares_owned_after_display":"575,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-27","filed_date":"2021-08-27","scope":"insider","n_lines":2},{"id":5164290,"accession":"0001209191-21-053763","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-053763","line_url":"/filing/0001209191-21-053763","is_derivative":false,"issuer_cik":"0001422772","issuer_name":"Applied Molecular Transport Inc.","issuer_ticker":"AMTI","issuer_name_source":null,"issuer_url":"/issuer/0001422772","owner_cik":"0001422772","owner_name":"Kim Helen Susan","owner_display_name":"Kim Helen Susan","owner_url":"/insider/0001422772","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14063.0,"shares_display":"14,063","price_per_share":30.15531394439309,"price_display":"30.16","price_state":"stated","total_value":424074.18,"total_display":"424,074.18","total_whole":"424,074","shares_owned_after":576509.0,"shares_owned_after_display":"576,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-26","filed_date":"2021-08-27","scope":"insider","n_lines":2},{"id":4182851,"accession":"0001209191-21-053411","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-053411","line_url":"/filing/0001209191-21-053411#line-3","is_derivative":false,"issuer_cik":"0001422772","issuer_name":"Applied Molecular Transport Inc.","issuer_ticker":"AMTI","issuer_name_source":null,"issuer_url":"/issuer/0001422772","owner_cik":"0001422772","owner_name":"Kim Helen Susan","owner_display_name":"Kim Helen Susan","owner_url":"/insider/0001422772","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9478.0,"shares_display":"9,478","price_per_share":30.0776,"price_display":"30.08","price_state":"stated","total_value":285075.4928,"total_display":"285,075.49","total_whole":"285,075","shares_owned_after":590014.0,"shares_owned_after_display":"590,014","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-25","filed_date":"2021-08-25","scope":"insider"},{"id":4182849,"accession":"0001209191-21-053411","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-053411","line_url":"/filing/0001209191-21-053411","is_derivative":false,"issuer_cik":"0001422772","issuer_name":"Applied Molecular Transport Inc.","issuer_ticker":"AMTI","issuer_name_source":null,"issuer_url":"/issuer/0001422772","owner_cik":"0001422772","owner_name":"Kim Helen Susan","owner_display_name":"Kim Helen Susan","owner_url":"/insider/0001422772","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":508.0,"shares_display":"508","price_per_share":30.03005905511811,"price_display":"30.03","price_state":"stated","total_value":15255.27,"total_display":"15,255.27","total_whole":"15,255","shares_owned_after":599495.0,"shares_owned_after_display":"599,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-24","filed_date":"2021-08-25","scope":"insider","n_lines":2},{"id":5293224,"accession":"0001209191-21-045674","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-045674","line_url":"/filing/0001209191-21-045674","is_derivative":false,"issuer_cik":"0001422772","issuer_name":"Applied Molecular Transport Inc.","issuer_ticker":"AMTI","issuer_name_source":null,"issuer_url":"/issuer/0001422772","owner_cik":"0001422772","owner_name":"Kim Helen Susan","owner_display_name":"Kim Helen Susan","owner_url":"/insider/0001422772","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":43.3186528505,"price_display":"43.32","price_state":"stated","total_value":8663730.5701,"total_display":"8,663,730.57","total_whole":"8,663,731","shares_owned_after":601241.0,"shares_owned_after_display":"601,241","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-02","filed_date":"2021-07-06","scope":"insider","n_lines":2},{"id":4542346,"accession":"0001209191-17-054199","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-054199","line_url":"/filing/0001209191-17-054199#line-2","is_derivative":false,"issuer_cik":"0001422772","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001422772","owner_cik":"0001422772","owner_name":"Kim Helen Susan","owner_display_name":"Kim Helen Susan","owner_url":"/insider/0001422772","role":"Officer (EVP, Business Development)","role_mark":"O","role_mark_label":"Officer (EVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3171.0,"shares_display":"3,171","price_per_share":179.6639,"price_display":"179.66","price_state":"stated","total_value":569714.2269,"total_display":"569,714.23","total_whole":"569,714","shares_owned_after":21693.0,"shares_owned_after_display":"21,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-25","filed_date":"2017-09-27","scope":"insider"},{"id":4832523,"accession":"0001209191-17-048786","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-048786","line_url":"/filing/0001209191-17-048786#line-3","is_derivative":false,"issuer_cik":"0001422772","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001422772","owner_cik":"0001422772","owner_name":"Kim Helen Susan","owner_display_name":"Kim Helen Susan","owner_url":"/insider/0001422772","role":"Officer (EVP, Business Development)","role_mark":"O","role_mark_label":"Officer (EVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6251.0,"shares_display":"6,251","price_per_share":120.09,"price_display":"120.09","price_state":"stated","total_value":750682.59,"total_display":"750,682.59","total_whole":"750,683","shares_owned_after":18664.0,"shares_owned_after_display":"18,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-10","filed_date":"2017-08-14","scope":"insider"},{"id":4267740,"accession":"0001209191-17-048434","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-17-048434","line_url":"/filing/0001209191-17-048434","is_derivative":false,"issuer_cik":"0001422772","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001422772","owner_cik":"0001422772","owner_name":"Kim Helen Susan","owner_display_name":"Kim Helen Susan","owner_url":"/insider/0001422772","role":"Officer (EVP, Business Development)","role_mark":"O","role_mark_label":"Officer (EVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":79949.0,"shares_display":"79,949","price_per_share":119.55526272999037,"price_display":"119.56","price_state":"stated","total_value":9558323.7,"total_display":"9,558,323.70","total_whole":"9,558,324","shares_owned_after":31938.0,"shares_owned_after_display":"31,938","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-08","filed_date":"2017-08-10","scope":"insider","n_lines":6},{"id":4871001,"accession":"0001209191-17-046974","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-17-046974","line_url":"/filing/0001209191-17-046974","is_derivative":false,"issuer_cik":"0001422772","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001422772","owner_cik":"0001422772","owner_name":"Kim Helen Susan","owner_display_name":"Kim Helen Susan","owner_url":"/insider/0001422772","role":"Officer (EVP, Business Development)","role_mark":"O","role_mark_label":"Officer (EVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26649.0,"shares_display":"26,649","price_per_share":109.28261735900034,"price_display":"109.28","price_state":"stated","total_value":2912272.47,"total_display":"2,912,272.47","total_whole":"2,912,272","shares_owned_after":29509.0,"shares_owned_after_display":"29,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-01","scope":"insider","n_lines":4},{"id":4266693,"accession":"0001209191-17-037803","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-037803","line_url":"/filing/0001209191-17-037803#line-2","is_derivative":false,"issuer_cik":"0001422772","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001422772","owner_cik":"0001422772","owner_name":"Kim Helen Susan","owner_display_name":"Kim Helen Susan","owner_url":"/insider/0001422772","role":"Officer (EVP, Business Development)","role_mark":"O","role_mark_label":"Officer (EVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":72.45,"price_display":"72.45","price_state":"stated","total_value":173880.0,"total_display":"173,880.00","total_whole":"173,880","shares_owned_after":18664.0,"shares_owned_after_display":"18,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-01","filed_date":"2017-06-05","scope":"insider"},{"id":4869135,"accession":"0001209191-17-029754","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-029754","line_url":"/filing/0001209191-17-029754#line-2","is_derivative":false,"issuer_cik":"0001422772","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001422772","owner_cik":"0001422772","owner_name":"Kim Helen Susan","owner_display_name":"Kim Helen Susan","owner_url":"/insider/0001422772","role":"Officer (EVP, Business Development)","role_mark":"O","role_mark_label":"Officer (EVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":82.12,"price_display":"82.12","price_state":"stated","total_value":197088.0,"total_display":"197,088.00","total_whole":"197,088","shares_owned_after":18664.0,"shares_owned_after_display":"18,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-01","filed_date":"2017-05-03","scope":"insider"},{"id":4322009,"accession":"0001209191-17-024743","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-024743","line_url":"/filing/0001209191-17-024743#line-2","is_derivative":false,"issuer_cik":"0001422772","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001422772","owner_cik":"0001422772","owner_name":"Kim Helen Susan","owner_display_name":"Kim Helen Susan","owner_url":"/insider/0001422772","role":"Officer (EVP, Business Development)","role_mark":"O","role_mark_label":"Officer (EVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":81.8,"price_display":"81.80","price_state":"stated","total_value":196320.0,"total_display":"196,320.00","total_whole":"196,320","shares_owned_after":18664.0,"shares_owned_after_display":"18,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-03","filed_date":"2017-04-04","scope":"insider"},{"id":5095551,"accession":"0000899243-17-005888","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0000899243-17-005888","line_url":"/filing/0000899243-17-005888","is_derivative":false,"issuer_cik":"0001422772","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001422772","owner_cik":"0001422772","owner_name":"Kim Helen Susan","owner_display_name":"Kim Helen Susan","owner_url":"/insider/0001422772","role":"Officer (EVP, Business Development)","role_mark":"O","role_mark_label":"Officer (EVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":75.43291666666667,"price_display":"75.43","price_state":"stated","total_value":181039.0,"total_display":"181,039.00","total_whole":"181,039","shares_owned_after":19064.0,"shares_owned_after_display":"19,064","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-01","filed_date":"2017-03-02","scope":"insider","n_lines":9},{"id":5095501,"accession":"0000899243-17-005888","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000899243-17-005888","line_url":"/filing/0000899243-17-005888","is_derivative":false,"issuer_cik":"0001422772","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001422772","owner_cik":"0001422772","owner_name":"Kim Helen Susan","owner_display_name":"Kim Helen Susan","owner_url":"/insider/0001422772","role":"Officer (EVP, Business Development)","role_mark":"O","role_mark_label":"Officer (EVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47900.0,"shares_display":"47,900","price_per_share":67.39816012526096,"price_display":"67.40","price_state":"stated","total_value":3228371.87,"total_display":"3,228,371.87","total_whole":"3,228,372","shares_owned_after":46092.0,"shares_owned_after_display":"46,092","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-28","filed_date":"2017-03-02","scope":"insider","n_lines":9},{"id":2290066,"accession":"0001209191-16-156549","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-156549","line_url":"/filing/0001209191-16-156549#line-1","is_derivative":false,"issuer_cik":"0001422772","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001422772","owner_cik":"0001422772","owner_name":"Kim Helen Susan","owner_display_name":"Kim Helen Susan","owner_url":"/insider/0001422772","role":"Officer (EVP, Business Development)","role_mark":"O","role_mark_label":"Officer (EVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":936.0,"shares_display":"936","price_per_share":50.86,"price_display":"50.86","price_state":"stated","total_value":47604.96,"total_display":"47,604.96","total_whole":"47,605","shares_owned_after":8064.0,"shares_owned_after_display":"8,064","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-20","filed_date":"2016-12-22","scope":"insider"},{"id":3085561,"accession":"0001209191-16-137390","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-137390","line_url":"/filing/0001209191-16-137390#line-4","is_derivative":false,"issuer_cik":"0001422772","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001422772","owner_cik":"0001422772","owner_name":"Kim Helen Susan","owner_display_name":"Kim Helen Susan","owner_url":"/insider/0001422772","role":"Officer (EVP, Business Development)","role_mark":"O","role_mark_label":"Officer (EVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":63.012,"price_display":"63.01","price_state":"stated","total_value":151228.8,"total_display":"151,228.80","total_whole":"151,229","shares_owned_after":9000.0,"shares_owned_after_display":"9,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-15","filed_date":"2016-08-16","scope":"insider"},{"id":3085555,"accession":"0001209191-16-137390","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-137390","line_url":"/filing/0001209191-16-137390#line-2","is_derivative":false,"issuer_cik":"0001422772","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001422772","owner_cik":"0001422772","owner_name":"Kim Helen Susan","owner_display_name":"Kim Helen Susan","owner_url":"/insider/0001422772","role":"Officer (EVP, Business Development)","role_mark":"O","role_mark_label":"Officer (EVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33500.0,"shares_display":"33,500","price_per_share":60.0775,"price_display":"60.08","price_state":"stated","total_value":2012596.25,"total_display":"2,012,596.25","total_whole":"2,012,596","shares_owned_after":9000.0,"shares_owned_after_display":"9,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-12","filed_date":"2016-08-16","scope":"insider"},{"id":2899023,"accession":"0001181431-08-019123","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001181431-08-019123","line_url":"/filing/0001181431-08-019123#line-11","is_derivative":false,"issuer_cik":"0001110206","issuer_name":"KOSAN BIOSCIENCES INC","issuer_ticker":"KOSN","issuer_name_source":null,"issuer_url":"/issuer/0001110206","owner_cik":"0001422772","owner_name":"Kim Helen Susan","owner_display_name":"Kim Helen Susan","owner_url":"/insider/0001422772","role":"Officer (President, CBO)","role_mark":"O","role_mark_label":"Officer (President, CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CBO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4900.0,"shares_display":"4,900","price_per_share":1.65,"price_display":"1.65","price_state":"stated","total_value":8085.0,"total_display":"8,085.00","total_whole":"8,085","shares_owned_after":6039.0,"shares_owned_after_display":"6,039","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-14","filed_date":"2008-03-17","scope":"insider"},{"id":2899019,"accession":"0001181431-08-019123","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001181431-08-019123","line_url":"/filing/0001181431-08-019123#line-10","is_derivative":false,"issuer_cik":"0001110206","issuer_name":"KOSAN BIOSCIENCES INC","issuer_ticker":"KOSN","issuer_name_source":null,"issuer_url":"/issuer/0001110206","owner_cik":"0001422772","owner_name":"Kim Helen Susan","owner_display_name":"Kim Helen Susan","owner_url":"/insider/0001422772","role":"Officer (President, CBO)","role_mark":"O","role_mark_label":"Officer (President, CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CBO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2641.0,"shares_display":"2,641","price_per_share":1.7,"price_display":"1.70","price_state":"stated","total_value":4489.7,"total_display":"4,489.70","total_whole":"4,490","shares_owned_after":10280.0,"shares_owned_after_display":"10,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-14","filed_date":"2008-03-17","scope":"insider"},{"id":2899015,"accession":"0001181431-08-019123","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001181431-08-019123","line_url":"/filing/0001181431-08-019123#line-9","is_derivative":false,"issuer_cik":"0001110206","issuer_name":"KOSAN BIOSCIENCES INC","issuer_ticker":"KOSN","issuer_name_source":null,"issuer_url":"/issuer/0001110206","owner_cik":"0001422772","owner_name":"Kim Helen Susan","owner_display_name":"Kim Helen Susan","owner_url":"/insider/0001422772","role":"Officer (President, CBO)","role_mark":"O","role_mark_label":"Officer (President, CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CBO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2400.0,"shares_display":"2,400","price_per_share":1.66,"price_display":"1.66","price_state":"stated","total_value":3984.0,"total_display":"3,984.00","total_whole":"3,984","shares_owned_after":15800.0,"shares_owned_after_display":"15,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-14","filed_date":"2008-03-17","scope":"insider"}],"collapsed":true,"next_cursor":"2008-03-14|2899015","ledger_fault":false,"count":{"value":58,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":13,"open_market":true},{"code":"S","label":"Open-market sale","n":45,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":58},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0002035832","name":"Aktis Oncology, Inc.","url":"/issuer/0002035832","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2026-01-12","last_seen":"2026-01-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001801777","name":"Applied Molecular Transport Inc.","url":"/issuer/0001801777","role":"Director","n_filings":3,"first_seen":"2021-07-06","last_seen":"2021-08-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001510580","name":"Kite Pharma, Inc.","url":"/issuer/0001510580","role":"Officer (EVP, Business Development)","n_filings":10,"first_seen":"2016-08-16","last_seen":"2017-09-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001110206","name":"KOSAN BIOSCIENCES INC","url":"/issuer/0001110206","role":"Officer (President, CBO)","n_filings":1,"first_seen":"2008-03-17","last_seen":"2008-03-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001422772","retrieved_at":"2026-08-23T02:50:07+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}